Helicobacter Pylori Test Companies

Biomerica received US FDA 510(k) clearance for its Hp Detect™ ELISA Test, a new non-invasive stool antigen test for detecting H. pylori infection. This clearance opens up a significant market opportunity for Biomerica in the US, where an estimated 35% of the population is infected with H. pylori.

Meridian Bioscience announced the launch of its Meridian HpFAST® Urea Breath Test in Brazil, expanding its reach in the Latin American market for H. pylori testing. This test offers a quick and accurate means of diagnosing H. pylori infection.

Roche Diagnostics introduced the Elecsys® Anti- Helicobacter pylori IgG assay, a new automated immunoassay for serological detection of H. pylori infection. This assay offers high sensitivity and specificity, improving diagnostic accuracy.

Quidel Corporation launched the Sofia® H. pylori Antigen FIA test, a rapid point-of-care test for detecting H. pylori infection in stool samples. This test provides results in just 15 minutes, facilitating faster diagnosis and treatment decisions.

• 
  

  Thermo Fisher Scientific Inc. (US),

  
  


• 
  

  Bio-Rad Laboratories, Inc. (US),

  
  


• 
  

  Hoffmann-La Roche Ltd (Switzerland),

  
  


• 
  

  Quest Diagnostics Incorporated (US),

  
  


• 
  

  Meridian Bioscience (US),

  
  


• 
  

  CorisBioconcept SPRL (Belgium),

  
  


• 
  

  Cardinal Health (US),

  
  


• 
  

  QIAGEN (Germany),

  
  


• 
  

  Abbott Laboratories (US),

  
  


• 
  

  Biohit Oyj (Finland)